BackChromocell Therapeutics Overview

Chromocell Therapeutics Intangible Assets

Chromocell Therapeutics's intangible assets is $38M.

Get informed when a big investor buys or sells

+ Follow
Intangible Assets
$38.44M

Peer average

Loading

Chromocell Therapeutics Intangible Assets History

Loading

Chromocell Therapeutics vs. peers: Intangible Assets Comparison

Loading

Chromocell Therapeutics Intangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Chromocell Therapeutics (CHRO) FAQ

The latest intangible assets for CHRO is $38M as of March 2026. In the prior-year period, the figure was $0. Investors often review this figure alongside Chromocell Therapeutics's historical trend and sector peers before judging valuation or financial health.

Over the past year, CHRO's intangible assets moved from $0 to $38M. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Chromocell Therapeutics's operating scale or balance-sheet position.

A intangible assets figure of $38M for CHRO is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting CHRO's intangible assets ($38M), review year-over-year change from $0, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.